found raised blood levels of MCP-1/CCL2 and IP-10/CXCL10 in non-hospitalized COVID-19 patients at 6 months follow-up, which levels did not correlate with fatigue severity (66), similar to our findings in hospitalized patients. The gene discussed is CXCL10; the disease is COVID-19.